The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Skye Bioscience Inc shares valued at $582,936 were sold by Schwab Andrew J. on Aug 22 ’25. At $3.42 per share, Schwab Andrew J. sold 170,449 shares. The insider’s holdings dropped to 57,493 shares worth approximately $0.22 million following the completion of this transaction.
Also, Schwab Andrew J. sold 60,956 shares, netting a total of over 217,613 in proceeds. Following the sale of shares at $3.57 each, the insider now holds 63,963 shares.
Before that, 5AM Partners VII, LLC had sold 170,449 shares from its account. In a trade valued at $582,936, the 10% Owner traded Skye Bioscience Inc shares for $3.42 each. Upon closing the transaction, the insider’s holdings decreased to 170,449 shares, worth approximately $0.22 million.
As published in their initiating research note from Evercore ISI on August 15, 2025, Skye Bioscience Inc [SKYE] has been an Outperform and the price target has been revised to $10. Analysts at William Blair started covering the stock with ‘”an Outperform”‘ outlook in a report released in late February. As of September 30, 2024, Scotiabank has initiated its “Sector outperform” rating for SKYE. Earlier on September 10, 2024, JMP Securities initiated its rating. Their recommendation was “a Mkt outperform” for SKYE stock.
Analyzing SKYE Stock Performance
On last trading session, Skye Bioscience Inc [NASDAQ: SKYE] rose 11.61% to $3.75. The stock’s lowest price that day was $3.3808, but it reached a high of $3.77 in the same session. During the last five days, there has been a surge of approximately 8.38%. Over the course of the year, Skye Bioscience Inc shares have dropped approximately -39.42%. Shares of the company reached a 52-week high of $5.75 on 06/27/25 and a 52-week low of $1.14 on 04/08/25.
Support And Resistance Levels for Skye Bioscience Inc (SKYE)
According to the 24-hour chart, there is a support level at 3.50, which, if violated, would cause prices to drop to 3.24. In the upper region, resistance lies at 3.89. The next price resistance is at 4.02. RSI (Relative Strength Index) is 56.57 on the 14-day chart, showing neutral technical sentiment.
Is Skye Bioscience Inc subject to short interest?
Stocks of Skye Bioscience Inc saw a sharp steep in short interest on 2025-08-15 dropping by 9829.0 shares to 2.67 million. Data from Yahoo Finance shows that the short interest on 2025-07-15 was 2.68 million shares. A decline of -0.37% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 7.41 of the overall float, the days-to-cover ratio (short ratio) decline to 7.41.
Which companies own the most shares of Skye Bioscience Inc (SKYE)?
In terms of Skye Bioscience Inc share price expectations, FactSet research, analysts set an average price target of 20 in the next 12 months, up nearly 495.24% from the previous closing price of $3.36. Analysts anticipate Skye Bioscience Inc stock to reach 21 by 2025, with the lowest price target being 15. In spite of this, 3 analysts ranked Skye Bioscience Inc stock as Buy at the end of 2025. On July 09, 2024, Craig Hallum assigned a price target of “a Buy” to the stock and initiated coverage with a $18.
